X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. FRESENIUS KABI ONCO. FDC LTD./
FRESENIUS KABI ONCO.
 
P/E (TTM) x 17.5 22.1 79.0% View Chart
P/BV x 3.6 3.1 117.0% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    FDC LTD.
Mar-14
FRESENIUS KABI ONCO.
Mar-13
FDC LTD./
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs144176 81.5%   
Low Rs7979 100.6%   
Sales per share (Unadj.) Rs47.637.7 126.2%  
Earnings per share (Unadj.) Rs7.65.1 149.4%  
Cash flow per share (Unadj.) Rs9.06.7 134.0%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.542.5 111.7%  
Shares outstanding (eoy) m177.83158.23 112.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.4 69.3%   
Avg P/E ratio x14.625.0 58.5%  
P/CF ratio (eoy) x12.318.9 65.2%  
Price / Book Value ratio x2.33.0 78.2%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78420,135 98.3%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m1,221703 173.6%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m8,4595,963 141.8%  
Other income Rs m39418 2,186.4%   
Total revenues Rs m8,8525,981 148.0%   
Gross profit Rs m2,0701,430 144.8%  
Depreciation Rs m249258 96.6%   
Interest Rs m31-26 -119.3%   
Profit before tax Rs m2,1841,216 179.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m606342 177.0%   
Profit after tax Rs m1,353806 167.9%  
Gross profit margin %24.524.0 102.0%  
Effective tax rate %27.728.1 98.6%   
Net profit margin %16.013.5 118.4%  
BALANCE SHEET DATA
Current assets Rs m4,3555,102 85.4%   
Current liabilities Rs m1,7922,385 75.1%   
Net working cap to sales %30.345.6 66.5%  
Current ratio x2.42.1 113.6%  
Inventory Days Days44150 29.6%  
Debtors Days Days25113 21.8%  
Net fixed assets Rs m3,0255,148 58.8%   
Share capital Rs m179158 112.9%   
"Free" reserves Rs m8,2436,556 125.7%   
Net worth Rs m8,4536,732 125.6%   
Long term debt Rs m11952 1.1%   
Total assets Rs m10,55710,388 101.6%  
Interest coverage x71.4-45.8 -156.0%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.80.6 139.6%   
Return on assets %13.17.5 174.6%  
Return on equity %16.012.0 133.7%  
Return on capital %23.514.6 161.0%  
Exports to sales %13.374.5 17.9%   
Imports to sales %3.324.8 13.5%   
Exports (fob) Rs m1,1264,441 25.4%   
Imports (cif) Rs m2831,477 19.1%   
Fx inflow Rs m1,1465,298 21.6%   
Fx outflow Rs m3551,772 20.0%   
Net fx Rs m7913,525 22.4%   
CASH FLOW
From Operations Rs m1,4851,274 116.5%  
From Investments Rs m-620-1,204 51.4%  
From Financial Activity Rs m-753-196 383.7%  
Net Cashflow Rs m113-126 -89.3%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 4.7 0.3 1,566.7%  
FIIs % 7.5 9.6 78.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 9.1 208.8%  
Shareholders   23,730 42,599 55.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Negative Note; IT Sector Down 2.4%(11:30 am)

After opening the day on a negative note, share markets in India continued to witness losses. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 12:56 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - JUBILANT LIFE SCIENCES COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS